A Resource for Healthcare and Social Services Professionals
Estimated time to complete: 45 minutes
This training will provide strategies for pain management in patients with co-occurring pain and opioid use disorder. CEs: CME (0.75); Nursing (0.75), Pharmacology (0.75)
This training will provide strategies for pain management in patients with co-occurring pain and opioid use disorder.
This training satisfies 0.75 hours of the required 8 hours of training for DEA-registered practitioners. The Medication Access and Training Expansion (MATE) Act was included in the Consolidated Appropriations Act, 2023. The MATE Act requires increased training for Drug Enforcement Administration (DEA)-registered physicians and practitioners—specifically, a one-time eight-hour training requirement on treating and managing patients with opioid or other substance use disorders.
Medical professionals with prescriptive authority, nurses and support staff who support them looking to increase provision of care for patients with substance use disorder.
Other Faculty
Daniel P. Alford, MD, MPH, FACP, FASAM, CME Course Director, has no relevant financial relationships to disclose.
Colleen LaBelle, Planning Committee
Ilana Hardesty, MA, Planning Committee
Victoria Rust, BS, Planning Committee
Members of the planning committee have no relevant financial relationships to disclose.
Raagini Jawa, MD, MPH, FASAM (she/her)
Dr. Jawa is an Assistant Professor in the Division of General Internal Medicine and a clinician investigator in the Center for Research on Health Care at the University of Pittsburgh. She is board certified in Internal Medicine, Infectious Disease and Addiction Medicine. Dr. Jawa's research focuses on studying implementation of harm reduction services for individuals with substance use disorders within health settings, developing multidisciplinary provider facing interventions to prevent, diagnose, and treat infectious and non-infections complications of drug use. Clinically, she specializes in providing low-barrier skin and soft tissue infection and wound care, office-based addiction treatment in the Internal Medicine Recovery Engagement Program, and is a consulting specialist on the Endovascular Infection Service at University of Pittsburgh Medical Center. Dr. Jawa completed her MD-MPH at Boston University Chobanian & Avedisian School of Medicine, and her Internal Medicine and Chief residency and Combined Infectious Disease and Addiction Medicine Fellowship at Boston Medical Center.
Dr. Jawa has no relevant financial relationships to disclose.
Following this training, participants will have the knowledge necessary to:
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
To earn credit, one must complete the pre-test, video, and pass the post-test evaluation. The evaluation closes two weeks after watching the video.
Continuing Medical Education (CME)
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of Release: 7/11/23
Date of Expiration: 7/11/24
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
Faculty members do not plan on discussing off-label/investigational uses of a commercial product.
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
Contact Hours for Nurses
Boston Medical Center is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Participants who complete the entire session, return the evaluation, and pass the post-test with a score of 70% will be awarded 0.75 contact hours, 0.75 of which are classified as pharmacology.
This course expires on 7/14/2024
None of the planners or speakers have a financial relationship to disclose with ineligible companies.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.